The Zacks Analyst Blog Highlights Meta Platforms, Netflix, Pfizer, SIFCO Industries and Altigen Communications
Meta's AI push lifts engagement, Netflix eyes revenue doubling by 2030, and Pfizer leans on new launches to offset looming patent cliffs.
Zacks·12d ago
Top Research Reports for Meta, Netflix & Pfizer
Meta Platforms, Netflix and Pfizer lead fresh research as AI bets, bold 2030 goals and patent cliffs shape their outlooks.
Zacks·13d ago
ATGN's Earnings Break Even in Q1, Down Y/Y Due to High Customer Churn
Altigen's fiscal Q1 results face revenue decline from legacy platform transition, but strong margins, cost control and upcoming AI launches signal potential growth in the second half of FY2026.
Zacks·30d ago
Zacks Initiates Coverage of Altigen With Neutral Recommendation
Uncover why Zacks initiated coverage on ATGN with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. See how cloud partnerships, Microsoft-focused solutions and a return to profitability balance against customer concentration and competitive pressure.